FDA label
What is Lyumjev used for?
Lyumjev contains insulin lispro. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “LYUMJEV® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Lyumjev?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Lyumjev, injection, solution
Indications and Usage, quoted from the label by Eli Lilly and Company (BLA761109). Cross-references to other label sections are left out.
LYUMJEV® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
Source: DailyMed label, set id c5a056e2-b568-4ca6-9ed8-79c010942d00, version 12, effective June 16, 2026. NDC 0002-7726, one of 7 listings for this product.
Questions
What is Lyumjev used for?
The FDA label says: “LYUMJEV® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.”
What drug class is Lyumjev?
FDA lists insulin lispro in the Insulin Analog established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.